Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sushi domain-containing protein 2 (SUSD2) is a type I transmembrane protein with a large extracellular domain comprising several functional motifs (Sushi domains, somatomedin B, AMOP, and von Willebrand factor type D domains) typically found in cell adhesion and immune-related proteins[1][2][3]. It is highly expressed in several cancer types, notably breast cancer, where it may promote tumor cell invasion, angiogenesis, and immune evasion by interacting with the immune-modulatory protein Galectin-1. SUSD2 is being explored as a novel therapeutic target and biomarker for tumor detection and patient stratification, especially in breast cancer. Its full physiological function remains incompletely characterized, but it is implicated in cell adhesion, cell cycle regulation, and tissue specificity, with restricted expression in most normal adult tissues[2][3][1].
Not established for any drug; however, antibody-based therapies targeting SUSD2 have been considered for cancer (mechanistically, such agents would target cell surface SUSD2 to mediate tumor cell killing)[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sushi domain-containing protein 2 (SUSD2).